Advances in the pharmacotherapy of Heart Failure: type 2 sodium-glucose cotransporter Inhibitors (SGLT2) as a therapeutic option. (2023). Research, Society and Development, 12(3), e12412340502. https://doi.org/10.33448/rsd-v12i3.40502